Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Apr. 02, 2016	Apr. 04, 2015
Cash Flows From Operating Activities
Net income (loss)	$ 255,625	$ (1,025,515)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of leasehold improvements and equipment	82,506	66,902
Amortization of intangibles	11,311	10,124
Share-based compensation expense	324,035	715,909
Allowance for doubtful trade receivables	$ (28,785)	13,526
Loss from disposal of equipment		17,475
Non-cash financing costs	$ 53,449	46,948
Changes in operating assets and liabilities:
Trade receivables	(1,850,739)	(341,270)
Inventories	1,464,561	502,645
Prepaid expenses and other assets	14,082	(81,584)
Accounts payable	(3,318,853)	(810,658)
Accrued expenses	47,995	149,894
Customer deposits and other	67,598	158,917
Deferred rent	(18,857)	(14,371)
Net cash used in operating activities	(2,896,072)	(591,058)
Cash Flows From Investing Activities
Purchases of leasehold improvements and equipment	(16,629)	(95,778)
Purchases of intangible assets	(15,000)	(5,000)
Net cash used in investing activities	(31,629)	(100,778)
Cash Flows From Financing Activities
Proceeds from issuance of common stock, net of issuance costs	480,000	0
Proceeds from exercise of stock options	93,872	0
Principal payments on loan payable	(146,795)	0
Principal payments on capital leases	(53,542)	(57,075)
Net cash provided by (used in) financing activities	373,535	(57,075)
Net decrease in cash	(2,554,166)	(748,911)
Cash Beginning of Period	5,549,672	3,964,750
Cash Ending of Period	2,995,506	3,215,839
Supplemental Disclosures of Cash Flow Information
Cash payments for interest	135,046	73,202
Supplemental Schedule of Noncash Investing Activity
Capital lease obligation incurred for purchases of equipment	0	303,933
Inventory supplied free of charge to Healthspan Research, LLC	20,318	0
Retirement of fully depreciated equipment - cost	26,666	0
Retirement of fully depreciated equipment - accumulated depreciation	$ (26,666)	$ 0